|Articles|November 1, 2011
- Pharmaceutical Executive-11-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2011
Red Light on the Access Autobahn
Advertisement
Articles in this issue
almost 15 years ago
Plant Managementalmost 15 years ago
The Road from No. 20almost 15 years ago
Five Yearsalmost 15 years ago
Spotlight on OTCsalmost 15 years ago
Invaralmost 15 years ago
Europe Tackles 'Advertising in Disguise' Fearsalmost 15 years ago
The Drug Shortages Strugglealmost 15 years ago
Euroservicealmost 15 years ago
Pharma's Visit to the Plastic Surgeonalmost 15 years ago
The Pharma Revolution RecalibratedAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5